Larimar Therapeutics Inc. buy Global_Player
Start price
24.03.25
/
50%
€2.18
Target price
24.03.26
-
Performance (%)
-9.63%
End price
29.03.25
€1.97
Summary
This prediction ended on 29.03.25 with a price of €1.97. With a performance of -9.63%, the BUY prediction for Larimar Therapeutics Inc. by Global_Player closed slightly in the red. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Larimar Therapeutics Inc. | 5.143% | 5.143% | -2.128% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
According to Global_Player what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Zafgen Inc. diskutieren
Buy Larimar Therapeutics Inc.
In the thread Trading Zafgen Inc.
Stopped prediction by Global_Player for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.50
28.09.25
28.09.25
-
28.09.26
28.09.26
-20.89%
01.10.25
01.10.25
Could be worthwhile Investment >10% per year
